Sept 23 (Reuters) - Immutep Ltd IMM.AX :
* WILL RECEIVE A MILESTONE PAYMENT FROM GSK OF £4 MILLION
* PAYMENT RELATED TO FIRST PATIENT BEING DOSED IN GSK'S PHASE II CLINICAL TRIAL EVALUATING GSK2831781 IN ULCERATIVE COLITIS
Sept 23 (Reuters) - Immutep Ltd IMM.AX :
* WILL RECEIVE A MILESTONE PAYMENT FROM GSK OF £4 MILLION
* PAYMENT RELATED TO FIRST PATIENT BEING DOSED IN GSK'S PHASE II CLINICAL TRIAL EVALUATING GSK2831781 IN ULCERATIVE COLITIS